recently used six factors including total prostate-specific antigen, clinical tumor stage, Gleason score, prostate volume, red cell distribution width and serum alkaline phosphatase as the basis for constructing a nomogram model to predict the BM of PCa [9]. The gene discussed is KLK3; the disease is posterior cortical atrophy.